Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan 15;4(3):240-55.
doi: 10.7150/thno.6914. eCollection 2014.

Current progress in gene delivery technology based on chemical methods and nano-carriers

Affiliations
Review

Current progress in gene delivery technology based on chemical methods and nano-carriers

Lian Jin et al. Theranostics. .

Abstract

Gene transfer methods are promising in the field of gene therapy. Current methods for gene transfer include three major groups: viral, physical and chemical methods. This review mainly summarizes development of several types of chemical methods for gene transfer in vitro and in vivo by means of nano-carriers like; calcium phosphates, lipids, and cationic polymers including chitosan, polyethylenimine, polyamidoamine dendrimers, and poly(lactide-co-glycolide). This review also briefly introduces applications of these chemical methods for gene delivery.

Keywords: Chemical Methods.; Gene delivery; Non-viral; Vectors.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Fig 1
Fig 1
Primary physical methods for gene delivery.
Fig 2
Fig 2
Schematic representation of the structure of liposomes.
Fig 3
Fig 3
The schematic presentation of gene delivery process of polymers.
Fig 4
Fig 4
Primary applications of chitosan in biomedical fields.
Fig 5
Fig 5
Schematic representation of proton sponge effect of PEI polymer.
Fig 6
Fig 6
Two forms of PEI. (A) linear PEI, (B) branched PEI.

References

    1. Gupta A, Sharma A, von Boehmer L, Surace L, Knuth A, van den Broek M. Radiotherapy supports protective tumor-specific immunity. Oncoimmunology. 2012;1(9):1610–1611. - PMC - PubMed
    1. Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V, Fåhraeus R. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell. 2012;21(1):25–35. - PubMed
    1. Moon EK, Son M, Jin YW, Park S, Lee WJ. Variations of Lung Cancer Risk from Asbestos Exposure: Impact on estimation of population attributable fraction. Ind Health. 2013;51(1):128–133. - PubMed
    1. Chang HJ, Ko HL, Lee CY, Wu RH, Yeh YW, Jiang JS, Kao SJ, Chi KH. Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy. Radiat Oncol. 2012;7:222. - PMC - PubMed
    1. Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108(1):179–182. - PMC - PubMed

Publication types